title: Current and emerging therapeutic modalities for hyperhidrosis, part 2: moderately invasive and invasive procedures.
abstract: Hyperhidrosis (HH) hinders patient quality of life and causes the secondary effect of excess cutaneous sweat. Treatment modalities include conservative and noninvasive therapies such as topical agents and iontophoresis. This article reviews moderately invasive and invasive procedures, such as botulinum toxin, curettage, and endoscopic thoracic sympathectomy (ETS), and compares their advantages and disadvantages in safety and efficacy.
authors.affiliation: Cedars-Sinai Medical Center, University of Southern California, Keck School of Medicine, Department of Dermatology, Los Angeles, USA. dermatology@earthlink.net
authors.forename: Ramin
authors.initials: R
authors.lastname: Ram
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Lowe
authors.forename: Paul S
authors.initials: PS
authors.lastname: Yamauchi
mesh_terms: D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D003475:Curettage; D004724:Endoscopy; D006801:Humans; D006945:Hyperhidrosis / Q000601:surgery / Q000628:therapy*; D013562:Sympathectomy
chemical_list: D019274:Botulinum Toxins, Type A